Estimating the return-on-investment from changes in employee health risks on the Dow Chemical Company's health care costs

Journal of Occupational and Environmental Medicine

Volumn 47, Issue 8, 2005, Pages 759-768

  Goetzel, Ron Z ^a   Ozminkowski, Ronald J ^a,c   Baase, Catherine M ^b   Billotti, Gary M ^b  

^a MEDSTAT GROUP   (United States)

^b DOW CHEMICAL COMPANY   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL INDUSTRY; COST CONTROL; DEMOGRAPHY; EMPLOYEE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HUMAN; INVESTMENT; MULTIPLE REGRESSION; OCCUPATIONAL HAZARD; POPULATION RISK; PRODUCTIVITY; RETURN ON INVESTMENT; REVIEW; RISK REDUCTION;

EID: 23644439217     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000172868.05935.67     Document Type: Article

References (13)

1. Goetzel RZ, Juday TR, Ozminkowski RJ. What's the ROI?-A systematic review of return on investment (ROI) studies of corporate health and productivity management initiatives. AWHP's Worksite Health. 1999;12-21.
2. Serxner SA, Gold DB, Bultman KK. The impact of behavioral risk factors on worker absenteeism. J Occup Environ Med. 2001;43:347-354.
3. Ozminkowski RJ, Goetzel RZ. Getting closer to the truth: overcoming research challenges when estimating the financial impact of worksite health promotion programs. Am J Health Promot. 2001;15:289-295.
4. Chapman L. Proof Positive: Analysis of the Cost-Effectiveness of Worksite Wellness. Seattle, WA: Summex Corporation; 1999.
5. Aldana SG. Financial impact of worksite health promotion and methodological quality of the evidence. Art of Health Promot. 1998;2:1-8.
6. Aldana SG. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promot. 2001;15:296-320.
7. Goetzel RZ, Guindon AM, Turshen J, Ozminkowski RJ. Health and productivity management: establishing key performance measures, benchmarks, and best practices. J Occup Environ Med. 2001;43:10-17.
8. Dow Chemical Company. Internal Health and Productivity Management Bench-marking Report prepared by the Medstat Group, January 2001.
9. Leutzinger JA, Ozminkowski RJ, Dunn RL, et al. Projecting future medical care costs using four scenarios of lifestyle risk rates. Am J Health Promot. 2000;15:35-44.
10. Ozminkowski RJ, Goetzel RZ, Santoro J, Saenz BJ, Eley C, Gorsky B. Estimating risk reduction required to break even in a health promotion program. Am J Health Promot. 2004;18:316-325.
11. Goetzel RZ, Anderson DA, Whitmer RW, Ozminkowski RJ, Dunn RL, Wassserman J. The relationship between modifiable health risks and health care expenditures. J Occup Environ Med. 1998;40:843-854.
12. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
13. Goetzel RZ, Long S, Ozminkowski RJ, Hawkins, Wang S, Lynch W. Health, absence, disability and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004;46:398-412.